The story of Rakesh Shah is a compelling one of evolution and leadership. Though he began his career in finance and operations, areas seemingly distant from the medical field, he used these experiences as the very bedrock to his innovative approach to healthcare. Shah’s ability to translate skills from finance into effective healthcare strategies and
Leading Saudi-based IFM provider, Musanadah Facilities Management has secured membership with the International Sanitary Supply Association (ISSA), one of the world’s leading global industry associations for cleaning and facilities management. This membership marks a significant milestone for Musanadah, enhancing its ability to deliver benchmarked cleaning standards for hospitals and healthcare clinics across Saudi Arabia, adding
In celebration of World Heart Day, observed annually on September 29, Dubai Health recently announced the launch of the 2024 edition of the ‘Nabadat’ campaign for providing life-saving heart treatments for a total of 50 patients with congenital heart defects who cannot afford treatment. Now under Dubai Health, the campaign has expanded to include adults.
King Faisal Specialist Hospital and Research Center (KFSHRC) in Saudi Arabia has made medical history by successfully performing the world’s first complete robotic heart transplant on a 16-year-old patient suffering from stage four heart failure. This pioneering surgery, executed without traditional chest incisions, demonstrates Saudi Arabia’s growing prominence as a leader in cutting-edge healthcare and
CardiaTec, a techbio company decoding the biology behind cardiovascular disease, has announced securing €5.8 million in seed funding. The new funds will allow CardiaTec to expand its platform and progress proprietary drug targets to the preclinical stage. The round was led by Montage Ventures, with participation from other investors, such as Continuum Health Ventures and
An eye drop that can potentially replace reading glasses for middle-aged people was launched in India recently, following marketing authorisation approval by the Drugs Controller General of India (DCGI) last month. This will be India’s first such eye drop. The drug contains 1.25% pilocarpine hydrochloride and has been developed and launched by Mumbai-based pharmaceutical firm
The name — Botanical Chemist Palm Cove — has a natural ring to it. Inspired by the Daintree Rainforest and the Great Barrier Reef, where nature harbours a potential to throw upremedies, the organisation works diligently and leverages research and development to develop innovative treatments. With an emphasis on effective cure and sustainability, Botanical Chemist
Winnie LIW, the visionary Founder and CEO of Kingdom of Esther & WD TCM Lifestyle Products, has created a chemical-free universe where healing is both swift and devoid of harmful side effects. Her journey from the financial sector to the forefront of the beauty industry is a testament to her entrepreneurial spirit and commitment to
Johnson & Johnson (J&J) is in active negotiations with holdout plaintiffs’ attorneys over its proposed $6.5 billion settlement related to lawsuits claiming that its talc-based products, including baby powder, caused cancer. The pharmaceutical giant aims to resolve these legal challenges by securing a global settlement through the bankruptcy of a subsidiary despite previous rejections by
Elon Musk’s brain technology startup, Neuralink, has announced a successful outcome in its second human trial. It is a significant step forward in the company’s mission to enable paralyzed patients to control digital devices through thought alone. The patient, identified as Alex, received the brain implant and has not experienced the thread retraction issues that
